Triglyceride‐glucose index ( TyG index) and endometrial carcinoma risk: A retrospective cohort study
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15038 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Haimeng Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University Medical Schoo…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Endometrial Hyperplasia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
We analyzed the association between the triglyceride‐glucose index (TyG index) and incident endometrial carcinogenesis, aiming to determine whether the TyG index is a promising predictive biomarker for endometrial carcinoma (EC).
Methods
In this retrospective cohort study, multiple logistic regression analysis was performed to evaluate the relationship between TyG index and EC incidence and progression. The receiver operating characteristic (ROC) curve was used to calculate the area under the curve (AUC), as well as the cut‐off value of the TyG index for EC incidence.
Results
The TyG index was significantly higher in patients with EC or endometrial atypical hyperplasia (EAH) than in those with normal endometrium ( P < 0.001). A continuous rise was observed in the incidence of EC and EAH among the tertiles of the TyG index ( P < 0.001). The multiple logistic regression analysis revealed that the TyG index was associated with EC and EAH risk after adjusting for potential confounding factors (EAH: odds ratio [OR] 2.54, 95% confidence interval [CI] 1.33–4.85, P = 0.005; EC: OR 2.65, 95% CI 1.60–4.41, P < 0.001). Moreover, high TyG index was positively associated with advanced pathological stage (OR 2.14, 95% CI 1.32–3.47, P = 0.002) and poorer differentiation (OR 2.53, 95% CI 1.36–4.72, P = 0.004).
Conclusion
The TyG index might be a promising biomarker for endometrial carcinogenesis. Subjects with a higher TyG index should be aware of the risk of EC incidence and progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University Medical School, Nanjing, China.
- Department of Anesthesiology, Nanjing Pukou District Hospital of Chinese Medicine, Nanjing, China.
ORCID-Profile: Huaijun Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shi, H., Guo, F., Zheng, K., Li, R., & Zhou, H. (2024). Triglyceride‐glucose index ( TyG index) and endometrial carcinoma risk: A retrospective cohort study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15038
Vancouver
Shi H, Guo F, Zheng K, Li R, Zhou H. Triglyceride‐glucose index ( TyG index) and endometrial carcinoma risk: A retrospective cohort study. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15038
BibTeX
@article{Shi2024,
author = {Shi, Haimeng and Guo, Feifei and Zheng, Kang and Li, Rong and Zhou, Huaijun},
title = {Triglyceride‐glucose index ( TyG index) and endometrial carcinoma risk: A retrospective cohort study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15038}
}
EUVIMED